Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus

Genes and Immunity

Volumn 14, Issue 5, 2013, Pages 330-335

  Kuniholm, M H ^a   Anastos, K ^a,b   Kovacs, A ^c   Gao, X ^d,e   Marti, D ^d,e   Sette, A ^f   Greenblatt, R M ^g   Peters, M ^h   Cohen, M H ⁱ   Minkoff, H ^j   Gange, S J ^k   Thio, C L ^k   Young, M A ^l   Xue, X ^a   Carrington, M ^d,e   Strickler, H D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d SAIC FREDERICK INC   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Maimonides Medical Center ^*  (United States)

^j MAIMONIDES MEDICAL CENTER   (United States)

^k DEPARTMENT OF PATHOLOGY   (United States)

^l GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Hepatitis C virus; Human leukocyte antigen; Supertype

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ADULT; ALLELE; ARTICLE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SEROPREVALENCE; VIRAL CLEARANCE;

HEPATITIS C VIRUS;

EID: 84880917635     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.25     Document Type: Article

References (36)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714. (Pubitemid 46780630)
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-538. (Pubitemid 44307383)
3. Thimme R, Neumann-Haefelin C, Boettler T, Blum HE. Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine. Biol Chem 2008; 389: 457-467. (Pubitemid 351874195)
4. Burke KP, Cox AL. Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence. Immunol Res 2010; 47: 216-227.
5. Chang KM, Rehermann B, McHutchison JG, Pasquinelli C, Southwood S, Sette A et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest 1997; 100: 2376-2385. (Pubitemid 27500163)
6. Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL et al. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology 2010; 51: 1514-1522.
7. Sidney J, del Guercio MF, Southwood S, Engelhard VH, Appella E, Rammensee HG et al. Several HLA alleles share overlapping peptide specificities. J Immunol 1995; 154: 247-259.
8. Sidney J, Grey HM, Kubo RT, Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today 1996; 17: 261-266. (Pubitemid 26183489)
9. Lazaryan A, Lobashevsky E, Mulenga J, Karita E, Allen S, Tang J et al. Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans. J Virol 2006; 80: 6056-6060. (Pubitemid 43849183)
10. Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K et al. Human leukocyte antigen class I supertypes and HIV-1 control in African Americans. J Virol 2010; 84: 2610-2617.
11. Trachtenberg E, Korber B, Sollars C, Kepler TB, Hraber PT, Hayes E et al. Advantage of rare HLA supertype in HIV disease progression. Nat Med 2003; 9: 928-935. (Pubitemid 36889937)
12. Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV et al. Identification of HLA-A3 and-B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J Immunol 1999; 162: 1156-1164. (Pubitemid 29035448)
13. Wentworth PA, Sette A, Celis E, Sidney J, Southwood S, Crimi C et al. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int Immunol 1996; 8: 651-659. (Pubitemid 26148286)
14. Greenbaum J, Sidney J, Chung J, Brander C, Peters B, Sette A. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 2011; 63: 325-335.
15. Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, Worning P et al. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 2004; 55: 797-810. (Pubitemid 38650985)
16. Nielsen M, Lundegaard C, Blicher T, Peters B, Sette A, Justesen S et al. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: Net MHCIIpan. PLoS Comput Biol 2008; 4: e1000107.
17. Ou D, Mitchell LA, Tingle AJ. A new categorization of HLA DR alleles on a functional basis. Hum Immunol 1998; 59: 665-676. (Pubitemid 28436468)
18. Harris RA, Sugimoto K, Kaplan DE, Ikeda F, Kamoun M, Chang KM. Human leukocyte antigen class II associations with hepatitis C virus clearance and virusspecific CD4 T cell response among Caucasians and African Americans. Hepatology 2008; 48: 70-79. (Pubitemid 351975532)
19. Sette A, Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and-B polymorphism. Immunogenetics 1999; 50: 201-212. (Pubitemid 30099525)
20. Yu XG, Lichterfeld M, Chetty S, Williams KL, Mui SK, Miura T et al. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-aminoacid difference between HLA class I subtypes. J Virol 2007; 81: 1619-1631. (Pubitemid 46214437)
21. Eyster ME, Sanders J, Goedert JJ. Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia. Haemophilia 2004; 10: 75-80. (Pubitemid 38195629)
22. Raghuraman S, Park H, Osburn WO, Winkelstein E, Edlin BR, Rehermann B. Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J Infect Dis 2012; 205: 763-771.
23. Cano P, Fan B, Stass S. A geometric study of the amino acid sequence of class I HLA molecules. Immunogenetics 1998; 48: 324-334. (Pubitemid 28434641)
24. Tong JC, Tan TW, Ranganathan S. In silico grouping of peptide/HLA class I complexes using structural interaction characteristics. Bioinformatics 2007; 23: 177-183. (Pubitemid 46189607)
25. Mohanapriya A, Nandagond S, Shapshak P, Kangueane U, Kangueane P. A HLADRB supertype chart with potential overlapping peptide binding function. Bioinformation 2010; 4: 300-309.
26. Kangueane P, Sakharkar MK, Rajaseger G, Bolisetty S, Sivasekari B, Zhao B et al. A framework to sub-type HLA supertypes. Front Biosci 2005; 10: 879-886.
27. Doytchinova IA, Guan P, Flower DR. Identifiying human MHC supertypes using bioinformatic methods. J Immunol 2004; 172: 4314-4323. (Pubitemid 38375246)
28. Hertz T, Yanover C. Identifying HLA supertypes by learning distance functions. Bioinformatics 2007; 23: e148-e155. (Pubitemid 46189650)
29. Reche PA, Reinherz EL. Definition of MHC supertypes through clustering of MHC peptide-binding repertoires. Methods Mol Biol 2007; 409: 163-173.
30. Sidney J, Peters B, Frahm N, Brander C, Sette A. HLA class I supertypes: a revised and updated classification. BMC Immunol 2008; 9: 1.
31. Doytchinova IA, Flower DR. In silico identification of supertypes for class II MHCs. J Immunol 2005; 174: 7085-7095. (Pubitemid 40705674)
32. Kuo CL, Feingold E. What's the best statistic for a simple test of genetic association in a case-control study? Genet Epidemiol 2010; 34: 246-253.
33. Pybus OG, Cochrane A, Holmes EC, Simmonds P. The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol 2005; 5: 131-139. (Pubitemid 40090232)
34. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440-9445. (Pubitemid 37033947)
35. Westfall PH, Young SS. Resampling-Based Multiple Testing: Examples and Methods for P-Value Adjustment. Wiley-Interscience: New York, NY, 1993.
36. Nielsen M, Justesen S, Lund O, Lundegaard C, Buus S. NetMHCIIpan-2.0- Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res 2010; 6: 9.